Gene Review:
VIPR1 - vasoactive intestinal peptide receptor 1
Homo sapiens
Synonyms:
HVR1, II, PACAP type II receptor, PACAP-R-2, PACAP-R2, ...
- Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Sreedharan, S.P., Huang, J.X., Cheung, M.C., Goetzl, E.J. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells. el Battari, A., Martin, J.M., Luis, J., Pouzol, O., Secchi, J., Marvaldi, J., Pichon, J. J. Biol. Chem. (1988)
- Chromosomal localization in mouse and human of the vasoactive intestinal peptide receptor type 2 gene: a possible contributor to the holoprosencephaly 3 phenotype. Mackay, M., Fantes, J., Scherer, S., Boyle, S., West, K., Tsui, L.C., Belloni, E., Lutz, E., Van Heyningen, V., Harmar, A.J. Genomics (1996)
- Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68. Van Valen, F., Jürgens, H., Winkelmann, W., Keck, E. Cell. Signal. (1989)
- Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting. Dagar, S., Sekosan, M., Rubinstein, I., Onyüksel, H. Breast Cancer Res. Treat. (2001)
- AIDS and its dementia as a neuropeptide disorder: role of VIP receptor blockade by human immunodeficiency virus envelope. Pert, C.B., Smith, C.C., Ruff, M.R., Hill, J.M. Ann. Neurol. (1988)
- Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. Virgolini, I., Raderer, M., Kurtaran, A., Angelberger, P., Banyai, S., Yang, Q., Li, S., Banyai, M., Pidlich, J., Niederle, B., Scheithauer, W., Valent, P. N. Engl. J. Med. (1994)
- Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Vaudry, D., Gonzalez, B.J., Basille, M., Yon, L., Fournier, A., Vaudry, H. Pharmacol. Rev. (2000)
- CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. Fiorillo, M.T., Maragno, M., Butler, R., Dupuis, M.L., Sorrentino, R. J. Clin. Invest. (2000)
- Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig. Dupont, C., Broyart, J.P., Broer, Y., Chenut, B., Laburthe, M., Rosselin, G. J. Clin. Invest. (1981)
- The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature. el Battari, A., Luis, J., Martin, J.M., Fantini, J., Muller, J.M., Marvaldi, J., Pichon, J. Biochem. J. (1987)
- Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure. el Battari, A., Forget, P., Fouchier, F., Pic, P. Biochem. J. (1991)
- Vasoactive intestinal peptide receptor expression on human lymphoblasts. O'Dorisio, M.S., Shannon, B.T., Mulne, A.F., Zwick, D., Grossman, N.J., Ruymann, F.B. The American journal of pediatric hematology/oncology. (1992)
- Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y. Waschek, J.A., Muller, J.M., Duan, D.S., Sadée, W. FEBS Lett. (1989)
- Type 1 vasoactive intestinal peptide receptor expression in PC3/AR cells is evidence of prostate epithelial differentiation. Gkonos, P.J., Guo, F., Burnstein, K.L. Prostate (2000)
- Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis. Schratzberger, P., Geiseler, A., Dunzendorfer, S., Reinisch, N., Kähler, C.M., Wiedermann, C.J. J. Neuroimmunol. (1998)
- VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium. Chignard, N., Mergey, M., Barbu, V., Finzi, L., Tiret, E., Paul, A., Housset, C. Hepatology (2005)
- Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. Lara-Marquez, M., O'Dorisio, M., O'Dorisio, T., Shah, M., Karacay, B. J. Immunol. (2001)
- Cloning and expression of the human vasoactive intestinal peptide receptor. Sreedharan, S.P., Robichon, A., Peterson, K.E., Goetzl, E.J. Proc. Natl. Acad. Sci. U.S.A. (1991)
- Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. Xia, M., Sreedharan, S.P., Bolin, D.R., Gaufo, G.O., Goetzl, E.J. J. Pharmacol. Exp. Ther. (1997)
- Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors. Couvineau, A., Lacapere, J.J., Tan, Y.V., Rouyer-Fessard, C., Nicole, P., Laburthe, M. J. Biol. Chem. (2003)
- Vasoactive intestinal peptide (VIP) stimulates cortisol secretion from the H295 human adrenocortical tumour cell line via VPAC1 receptors. Nicol, M.R., Cobb, V.J., Williams, B.C., Morley, S.D., Walker, S.W., Mason, J.I. J. Mol. Endocrinol. (2004)
- Peptide Agonist Docking in the N-terminal Ectodomain of a Class II G Protein-coupled Receptor, the VPAC1 Receptor: PHOTOAFFINITY, NMR, AND MOLECULAR MODELING. Tan, Y.V., Couvineau, A., Murail, S., Ceraudo, E., Neumann, J.M., Lacapère, J.J., Laburthe, M. J. Biol. Chem. (2006)
- Identification of G-proteins coupling to the vasoactive intestinal peptide receptor VPAC(1) using immunoaffinity chromatography: evidence for precoupling. Martin Shreeve, S. Biochem. Biophys. Res. Commun. (2002)
- Pituitary adenylate cyclase-activating polypeptide stimulates secretion in T84 cells. Nguyen, T.D., Heintz, G.G., Cohn, J.A. Gastroenterology (1992)
- Signal transduction through the vasoactive intestinal peptide receptor stimulates phosphorylation of the tyrosine kinase pp60c-src. Koh, S.W. Biochem. Biophys. Res. Commun. (1991)
- Subset of cells immunopositive for neurokinin-1 receptor identified as arterial interstitial cells of Cajal in human large arteries. Bobryshev, Y.V. Cell Tissue Res. (2005)
- Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros. Dorsam, G., Goetzl, E.J. J. Biol. Chem. (2002)
- Shark rectal gland vasoactive intestinal peptide receptor: cloning, functional expression, and regulation of CFTR chloride channels. Bewley, M.S., Pena, J.T., Plesch, F.N., Decker, S.E., Weber, G.J., Forrest, J.N. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2006)
- Molecular cloning and functional characterization of a human liver vasoactive intestinal peptide receptor. Gagnon, A.W., Aiyar, N., Elshourbagy, N.A. Cell. Signal. (1994)
- Vasoactive intestinal peptide receptor activity and specificity during enterocyte-like differentiation and retrodifferentiation of the human colonic cancerous subclone HT29-18. Chastre, E., Emami, S., Rosselin, G., Gespach, C. FEBS Lett. (1985)
- Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. Alteration of receptor function by wheat germ agglutinin. Chochola, J., Fabre, C., Bellan, C., Luis, J., Bourgerie, S., Abadie, B., Champion, S., Marvaldi, J., el Battari, A. J. Biol. Chem. (1993)
- In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging. Reubi, J.C. J. Nucl. Med. (1995)
- Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours. Hessenius, C., Bäder, M., Meinhold, H., Böhmig, M., Faiss, S., Reubi, J.C., Wiedenmann, B. European journal of nuclear medicine. (2000)